Vitamin K2mk 7 Persuasive Speech Outline

Speech Assignment 11.1

State the organizational pattern chosen: Problem-Solution Pattern
Topic The Opportunity for Improved Quality and Length of Life by taking Vitamin K2MK-7
General Purpose To persuade the audience to take action
Specific Purpose Following my speech, the audience members will add Vitamin K2MK-7 to their daily diets.
Thesis By adding Vitamin K2MK-7 to your daily diet, you will achieve improved quality and length of life. Introduction
Gain audience attention I. If improved quality and length of life is important to you, then you are in the right place at the right time.
Establish S-A-T connection II. I am one of your neighbors here in the community. Many of you I have seen in the dining room, at the bar and at Association
The bad news is that most doctors will tell you that modern medicine has no answer of any kind to slow or stop the progression of Arterial Calcification. The good news is that the newly discovered MK-7 can halt and even reverse it.] Body
General statement of the problems to be discussed I. 50 years ago no one thought about or spoke about what we all know TODAY recognize as the dangers of a diet high in saturated fat, high in cholesterol, high in sugar, and high in simple carbohydrates. Had we known that 50 years ago, we would be much heathier today. First major problem A. Today we are learning that there are other things in our diets, or not in our diets, that are just as important, if not more important, than eating foods low in cholesterol, saturated fat and sugar. One of those things is MK-7. Supporting material for 1st major problem 1. All supporting material is distributed in a handout to the audience immediately following the conclusion of the speech. This is because the supporting material is extremely detailed, complex and scientific, and trying to bring it into the speech itself could cause distraction and audience frustration in trying to understand it. It is best read in a quiet isolated
Thank you for your enthusiasm tonight.

References

HANDOUT OF REFERENCES FOR AUDIENCE MEMBERS

1. M.H. Knapen, et al., “Menaquinone-7 Supplementation Improves Arterial Stiffness in Healthy Postmenopausal Women. A Double-Blind Randomised Clinical Trial,” Thromb. Haemost. 113(5), 1135–1144 (2015).
2. E.G.H.M. van den Heuvel, et al., “Circulating Uncarboxylated Matrix Gla Protein: A Marker of Vitamin K Status as a Risk Factor of Cardiovascular Disease,” Maturitas 77, 137–141 (2014)
3. G.W. Dalmeijer, et al., “Matrix Gla Protein Species and Risk of Cardiovascular Events in Type 2 Diabetic Patients,” Diabetes Care 36(11), 3766–3771 (2013).
4. R. Westenfeld, et al., “Effect of Vitamin K(2) Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial,” Am. J. Kidney Dis. 59(2), 86–95 (2012)
5. G.C.M. Gast, et al., “A High Menaquinone Intake Reduces the Incidence of Coronary Heart Disease,” Nutr. Metab. Cardiovasc. Dis. 19(7), 504–510 (2009)
6. J.M. Geleijnse, et al., “Dietary Intake of Menaquinone is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study,” J. Nutr. 134(11), 3100–3105